Zydus Cadila Plans Indian Remdesivir Entry In July

Interferon Studies In Mexico, IND in US

Zydus Cadila hopes to launch its version of Gilead’s remdesivir by end-July in India, even as earlier licensees Hetero Drugs and Cipla have just commercialized the antiviral. Plans for pegylated interferon alfa-2b to treat COVID-19 include a trial in Mexico and an IND in the US. Separately, desidustat is being considered for additional indications.

Remdesivir
Zydus Cadila - Another Remdesivir Contender In The Wings • Source: Shutterstock

More from Strategy

More from Business